Spironolactone May Reduce the Risk of Incident Rosacea

    Julia Spoendlin, Johannes J. Voegel, Susan S. Jick, Christoph Meier
    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study reports that spironolactone use was associated with a decreased risk of developing rosacea compared to other diuretics, particularly in current users without previous androgenic skin disease diagnoses.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results